Literature DB >> 17180355

[Modern diagnosis of Chlamydia trachomatis infections].

T Meyer1.   

Abstract

Chlamydia trachomatis is the most frequent sexually transmitted bacterial infection. Tests to diagnose C. trachomatis infections include growth on cell culture and assays detecting bacterial antigens or nucleic acids. Until recently, culture was considered the gold standard of testing because of its high specificity. However, the sensitivity of culture is limited. Nucleic acid amplification tests (NATs) have the highest sensitivity and are almost as specific as culture. They are best suited for screening. Chlamydial antigen EIAs are considerably less sensitive and specific, resulting in low positive predictive values, especially when low-prevalence populations are studied. Thus, positive results of chlamydia antigen EIAs should be confirmed by another test.

Entities:  

Mesh:

Year:  2007        PMID: 17180355     DOI: 10.1007/s00105-006-1266-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  24 in total

1.  Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.

Authors:  J Schachter; E W Hook; W M McCormack; T C Quinn; M Chernesky; S Chong; J I Girdner; P B Dixon; L DeMeo; E Williams; A Cullen; A Lorincz
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

Review 2.  Chlamydia trachomatis: impact on human reproduction.

Authors:  J Paavonen; W Eggert-Kruse
Journal:  Hum Reprod Update       Date:  1999 Sep-Oct       Impact factor: 15.610

3.  Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.

Authors:  Julius Schachter; Joan M Chow; Holly Howard; Gail Bolan; Jeanne Moncada
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.

Authors:  M R Howell; T C Quinn; W Brathwaite; C A Gaydos
Journal:  Sex Transm Dis       Date:  1998-02       Impact factor: 2.830

Review 5.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  Enhanced enzyme immunoassay with negative-gray-zone testing compared to a single nucleic Acid amplification technique for community-based chlamydial screening of men.

Authors:  Paddy Horner; Sue Skidmore; Alan Herring; Jo Sell; Ian Paul; Owen Caul; Matthias Egger; Anne McCarthy; Emma Sanford; Chris Salisbury; John Macleod; Jonathan Sterne; Nicola Low
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.

Authors:  Charlotte A Gaydos; Mellisa Theodore; Nicholas Dalesio; Billie Jo Wood; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  The chlamydia screening studies: rationale and design.

Authors:  N Low; A McCarthy; J Macleod; C Salisbury; P J Horner; T E Roberts; R Campbell; A Herring; S Skidmore; E Sanford; J A C Sterne; G Davey Smith; A Graham; M Huengsberg; J Ross; M Egger
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

9.  Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis.

Authors:  Julius Schachter; William M McCormack; Max A Chernesky; David H Martin; Barbara Van Der Pol; Peter A Rice; Edward W Hook; Walter E Stamm; Thomas C Quinn; Joan M Chow
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Antibodies to the chlamydial 60 kilodalton heat shock protein in women with tubal factor infertility.

Authors:  K A Ault; B D Statland; M M King; D I Dozier; M L Joachims; J Gunter
Journal:  Infect Dis Obstet Gynecol       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.